GP-Act III Acquisition Corp (GPAT) Stock Analysis

AI analysis of GP-Act III Acquisition Corp (GPAT)

Hold

GP-Act III Acquisition Corp. is currently priced at 11.10, which is close to its 52-week high of 12.00, indicating limited upside potential. The RSI is at 65.189, suggesting that the stock is nearing overbought territory. Additionally, the forward P/E ratio is 0, which indicates uncertainty about future earnings. The main risk is the significant drop in net income to common stockholders in Q2 2026, which fell to 290,121 from 3,304,297 in Q4 2024, highlighting potential operational issues.

Valuation Metrics

The current forward P/E ratio for GP-Act III Acquisition Corp (GPAT) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued

5Y Average P/E

0.00

Current P/E

0.00

Overvalued

0.00

Undervalued

0.00

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued

0.00

Undervalued

0.00

Forward P/S

Fair

5Y Average P/S

0.03

Current P/S

0.00

Overvalued

0.62

Undervalued

-0.56

Alphio AI Price Scenarios for GPAT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%GPAT

$10.98

Scenario price

B

Base

Base · 50%GPAT

$9.46

Scenario price

B

Bear

Bear · 25%GPAT

$8.29

Scenario price

Whales holding GPAT

P

Polar Asset Management Partners Inc.

+ HoldingGPAT

-2.91%

3M Return

GPAT FAQ — answered by Alphio AI

GP-Act III Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.

GP-Act III Acquisition Corp. is currently priced at 11.10, which is close to its 52-week high of 12.00, indicating limited upside potential. The RSI is at 65.189, suggesting that the stock is nearing overbought territory. Additionally, the forward P/E ratio is 0, which indicates uncertainty about future earnings. The main risk is the significant drop in net income to common stockholders in Q2 2026, which fell to 290,121 from 3,304,297 in Q4 2024, highlighting potential operational issues.